[Federal Register Volume 72, Number 145 (Monday, July 30, 2007)]
[Notices]
[Pages 41527-41528]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-14648]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in schedule I or II and prior to issuing a 
registration under 21 U.S.C. 952(a)(2) authorizing the importation of 
such a substance, provide manufacturers holding registrations for the 
bulk manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on June 6, 2007, Wildlife Laboratories, 1401 Duff Drive, Suite 
400, Fort Collins, Colorado 80524, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as an importer 
of Etorphine Hydrochloride (9059),a basic class of controlled substance 
listed in schedule II.
    The company plans to import the listed controlled substance for 
sale to its customers.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic class of controlled 
substance may file comments or objections to the issuance of the 
proposed registration and may, at the same time, file a written request 
for a hearing on such application pursuant to 21 CFR 1301.43 and in 
such form as prescribed by 21 CFR 1316.47.
    Any such comments or objections being sent via regular mail should 
be addressed, in quintuplicate, to the Drug Enforcement Administration, 
Office of Diversion Control, Federal Register Representative (ODL), 
Washington, DC 20537, or any being sent via express mail should be sent 
to Drug Enforcement Administration, Office of Diversion Control, 
Federal Register Representative (ODL), 2401 Jefferson Davis Highway, 
Alexandria, Virginia 22301; and must be filed no later than August 29, 
2007.
    This procedure is to be conducted simultaneously with, and 
independent

[[Page 41528]]

of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and 
(f). As noted in a previous notice published in the Federal Register on 
September 23, 1975, (40 FR 43745-46), all applicants for registration 
to import a basic class of any controlled substances in schedule I or 
II are and will continue to be required to demonstrate to the Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, that the requirements for such registration pursuant to 
21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), 
(e) and (f) are satisfied.

    Dated: July 24, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-14648 Filed 7-27-07; 8:45 am]
BILLING CODE 4410-09-P